ArticleJournal for immunotherapy of cancer2023

Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression.

Sofia Bruni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.